This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …

Differentiated thyroid cancer (DTC) is a rare malignant disease, although its incidence has
increased over the last few decades. It derives from follicular thyroid cells. Generally …

Thyroid cancer (TC) is the eighth most frequently diagnosed cancer worldwide with a rising
incidence in the past 20 years. Surgery is the primary strategy of therapy for patients with …

Anaplastic thyroid cancer (ATC) is one of the deadliest human cancers and it is less than 2%
of thyroid carcinomas (TCs). The standard treatment of ATC includes surgical debulking …

Background Reactivation of telomerase reverse transcriptase (TERT) is an important event
in cancer. Two hotspot mutations in the TERT promoter region, c.‐124C> T (C228T) and c …

ABSTRACT N6-methyladenosine (m6A) modification, the most abundant internal
methylation of eukaryotic RNA transcripts, is critically implicated in RNA processing. There is …

Introduction: Follicular-derived differentiated thyroid carcinoma (DTC) is the most common
endocrine and epithelial malignancy in children. The differences in the clinical and …

Concordance between mutations in the primary papillary thyroid carcinoma (PTC) and the
paired x lymph node metastasis may elucidate the potential role of molecular targeted …

Finding targetable gene fusions can expand the limited treatment options in radioactive
iodine-refractory (RAI-r) thyroid cancer. To that end, we established a novel cell line …

Purpose To evaluate whether if ultrasonography (US)-based radiomics enables prediction of
the presence of BRAFV600E mutations among patients diagnosed as papillary thyroid …